As in other malignancies, the HGF/Met axis is activated in CML and in MPN progenitors, due to the overproduction of HGF in the presence of normal or increased expression of Met. The gene discussed is HGF; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.